EGFR and neoplasm: EGFR could be evaluated in 45/96 (46.9%) samples with normal squamous epithelium, 116/131 (88.5%) samples with normal gastric mucosa, 53/73 (72.6%) samples with intestinal metaplasia (IM), 170/174 (97.7%) primary tumours and 71/81 (87.7%) metastases.